Prostate cancer is the second leading cause of cancer deaths among men.
The availability of animal models that represent the events and factors that exist in the natural history and biology of human prostate cancer is essential in dealing with prostate cancer. In recent decades and presently, emphasis has been directed at the development and employment of prostate cancer induced in transgenic mice. However, the important consistent hallmark characteristic and event of decrease in zinc and citrate and down regulation of ZIP1 zinc transporter in prostate malignancy has not been studied or identified in any animal model. We investigated the status of these parameters in TRAMP tumors as compared to human prostate cancer. The results show that citrate levels are markedly decreased in the developing and advancing stages of malignancy in TRAMP. Zinc levels are also decreased and ZIP1 transporter is lost in TRAMP tumors. In vitro studies show that zinc treatment of TRAMP C2 cells exhibits cytotoxic effects. Collectively, these results mimic the ZIP1, zinc, and citrate status and relationship that exist in human prostate cancer. This is the first report that establishes the existence of the human prostate zinc/citrate hallmark characteristic and relationship in an animal model. It now appears that the TRAMP model will be suitable for studies relating to the implications and role of zinc- and citrate-related metabolism in the development and progression of human prostate cancer.
Written by:
Costello LC, Franklin RB, Zou J, Feng P, Bok R, Mark G S, Kurhanewicz J. Are you the author?
University of Maryland Dental School and The University of Maryland Greenebaum Cancer Center, Baltimore, MD, USA.
Reference: Cancer Biol Ther. 2011 Dec 15;12(12). [Epub ahead of print]
PubMed Abstract
PMID: 22156800
UroToday.com Investigational Urology Section
